期刊文献+

IGF-1、TGF-β_1与2型糖尿病慢性并发症的关系 被引量:1

下载PDF
导出
摘要 目的检测2型糖尿病患者的血清胰岛素样生长因子1(IGF-1)、转化生长因子β1(TGF-β1)的水平,研究二者与糖尿病慢性并发症发生、发展的关系。方法根据不同临床情况,将2型糖尿病患者分为无并发症的糖尿病(DM)组、糖尿病肾病(DN)组、糖尿病视网膜病变(DR)组和糖尿病神经病变(DNP)组。采用ELISA法检测各组血清IGF-1、TGF-β1水平,并比较其与糖尿病慢性并发症的关系。结果与DM组比较,DR组IGF-1水平高,DNP组低(P<0.05);DN、DR和DNP组TGF-β1均高于DM组(P<0.05或<0.01);DN组24 h尿白蛋白和尿N-乙酰-β-D氨基葡萄糖苷酶均明显高于其他各组(P<0.01)。血清TGF-β1与尿白蛋白呈正相关(r=0.27,P<0.01)。结论 DR患者血清IGF-1水平升高,DNP患者血清IGF-1水平下降;DN的发生发展与血清TGF-β水平升高有密切关系。
出处 《山东医药》 CAS 北大核心 2010年第17期53-54,共2页 Shandong Medical Journal
  • 相关文献

参考文献5

  • 1Allard J,Buléon M,Cellier E,et al.ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats[J].Am J Physiol Renal Physiol,2007,293(4):F1083-1092.
  • 2Kubo E,Singh DP,Akagi Y.Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis[J].Diabetologia,2005,48(4):790-798.
  • 3Simó R,Carrasco E,García-Ramírez,et al.Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy[J].Curr Diabetes Rev,2006,2(1):71-98.
  • 4刘道平,汪寅章,黄兆坚.2型糖尿病患者血清GH、IGF-I浓度改变及相关因素的研究[J].中国糖尿病杂志,2000,8(2):81-84. 被引量:14
  • 5Garay-Sevilla ME,Nava LE,Malacara JM,et al.Advanced glycosylation end products (AGEs),insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus[J].Diabetes Metab Res Rev,2000,16(1):106-113.

二级参考文献1

共引文献13

同被引文献24

  • 1Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients at- tending hospital outpatients clinics[J]. Diabetes Metab, 2009, 35 (3) :206 - 213.
  • 2Partanen J, Niskanen L, Lehtinen J, et al. Natural history of pe- ripheral neuropathy in patients with non - insulin - dependent di- abetcs meUitus[J]. N Engl J Med, 1995, 333(2) :89 - 94.
  • 3Perkins BA, Olaleye D, Zinmam B, et al. Simple screening tests for peripheral neuropathy in the diabetes clinic [ J ]. Diabetes Care, 2001, 24(2):250-256.
  • 4Ukinc K, Ersoz HO, Karahan C, et al. Methyketrahydrofolate reductase C677T gene Mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy[J]. Endocrine, 2009, 36:255- 261.
  • 5Doupis J, Lyons TE, Wu S, et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy[J]. J Clin Endocrinol Metab, 2009, 94:2 157 - 2 163.
  • 6Pabreja K, Dua K, Sharma S, et al. Minocydine attenuates the de- velopmant of diabetic neuropathic pain.. Possible anti - in - flam- matory and anti - oxidant mechanisms [ J ]. Eur J Pharmacol, 2.011, 661:15-21.
  • 7Skundrik DS, Lisak RP. Role of neuropoitic cytokines in develop- ment and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration [J]. Exp Diabetol, 2003, 4 (3):303- 312.
  • 8Xie BG, Jin S, Zhu WJ. Expression of toll - like receptor 4 in ma- ternal monoeytes of patients with gestational diabetes mellitus[J ]. Exp Ther Med, 2014, 7(1) :236 - 240.
  • 9王友强,张磊,董砚虎,等.2型糖尿病周围神经病变与炎性因子超敏C反应蛋白、肿瘤坏死因子α水平研究[J].中华糖尿病杂志,2012,12(4):415-416.
  • 10Widiaja A, Stratton IM, Horn R, et al. UKPDS20: plasma lep- tin, obesity, and plasma insulin in type 2 diabetic subjects[J]. J Clin Endoerinol Metab, 1997, 82 : 654 - 657.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部